|
|
|
|
|
| |
Biomedcode Hellas SA, a spin off company of the Biomedical Sciences Research Center Alexander Fleming, has been established with the major goal of providing excellent services and superior value to biotechnology and pharmaceutical companies. Biomedcode provides full evaluation of therapeutics in unique complex transgenic animal models of human inflammatory and autoimmune diseases, such as Rheumatoid Arthritis, Crohn’s disease, Multiple Sclerosis, Cachexia and other disorders.
Our human TNF models of arthritis (Tg197, Tg5453) are recommended by the FDA for testing potential Rheumatoid Arthritis candidate drugs (FDA-Guidance for Industry Document).
| 
|
| Tg197 (human TNF) |
| A classic, unique, fast, and spontaneous in vivo model of human Rheumatoid Arthritis.
| |
|
| New Humanized Models |
| Biomedcode is currently developing human IL-17. human IL-33 and human RANKL transgenic mice. Contact us for more info.
| |
|
| Tghup55TNFR |
A New humanized model of p55TNF receptor I (huTNFRI) is now available!!!Shows normal regulation of the human p55 TNF receptor I, and can be crossed with any disease transgenic model in order to test anti-p55TNFRI therapeutics.
| |
|
|
| |
|
| |
|
 |
 |
| |
|
Biomedcode Offers Full Preclinical Drug Evaluation Services in Autoimmune and Inflammatory Disease Animal Models |
|
|
|
|
|
